Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
Yazar:: Xiaobin Wu, Runkun Han, Yanping Zhong, Nuoqing Weng, Ao Zhang
| Materyal Türü: | Article |
|---|---|
| Baskı/Yayın Bilgisi: | BMC 2021-12-01 |
Diğer Bilgiler
No description available for this item.